In a filing, Beam Therapeutics Inc revealed its SVP, Finance and Treasurer Cavanagh Bethany J unloaded Company’s shares for reported $0.22 million on Feb 18 ’25. In the deal valued at $35.00 per share,6,287 shares were sold. As a result of this transaction, Cavanagh Bethany J now holds 37,527 shares worth roughly $1.14 million.
Then, Bellon Christine sold 10,000 shares, generating $340,000 in total proceeds. Upon selling the shares at $34.00, the Chief Legal Officer now owns 102,968 shares.
Before that, CHRISTINE BELLON bought 10,000 shares. Beam Therapeutics Inc shares valued at $340,000 were divested by the Officer at a price of $34.00 per share.
Cantor Fitzgerald upgraded its Beam Therapeutics Inc [BEAM] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in early November from “a Market perform” to “an Outperform”. Scotiabank began covering BEAM with “Sector outperform” recommendation on October 16, 2024. H.C. Wainwright started covering the stock on July 23, 2024. It rated BEAM as “a Buy”.
Price Performance Review of BEAM
On Friday, Beam Therapeutics Inc [NASDAQ:BEAM] saw its stock fall -8.18% to $30.43. Over the last five days, the stock has gained 6.36%. Beam Therapeutics Inc shares have risen nearly 22.70% since the year began. Nevertheless, the stocks have fallen -4.31% over the past one year. While a 52-week high of $49.50 was reached on 02/18/25, a 52-week low of $20.84 was recorded on 01/15/25. SMA at 50 days reached $27.26, while 200 days put it at $25.58.
Levels Of Support And Resistance For BEAM Stock
The 24-hour chart illustrates a support level at 29.11, which if violated will result in even more drops to 27.79. On the upside, there is a resistance level at 32.83. A further resistance level may holdings at 35.23. The Relative Strength Index (RSI) on the 14-day chart is 57.12, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.38, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 44.12%. Stochastics %K at 75.32% indicates the stock is a holding.
